-
Considering writing into an international guide?
Time of Update: 2021-10-21
amount of weight can also reduce the life-changing, to help better manage blood sugar and blood pressure, reduce diabetes The risk of complications . ” commented Professor Lucy Chambers
-
Children also get thyroid nodules?
Time of Update: 2021-10-21
Most patients with benign thyroid nodules have no clinical symptoms, and some children may be accompanied by hypothyroidism and hyperthyroidism .
-
To sort out the management of patients with diabetes and CKD through cases and problems (Glucose Management)
Time of Update: 2021-10-21
Tests such as UKPDS and VADT have shown that, for patients with type 2 diabetes, intensive blood glucose control can reduce the incidence of CKD and the progression of kidney disease, but the impact on cardiovascular disease is limited .
-
Chongyang Special Edition Reveals the "Love, Hate and Enmity" between Thyroid Hormone and Health and Longevity (Part 2)
Time of Update: 2021-10-21
Therefore, when the general health status of the elderly changes recently, attention should be paid to screening thyroid function to rule out hyperthyroidism; delays in diagnosis and treatment can easily cause or aggravate elderly weakness and disability .
-
"Type 1 Diabetes" global circulation data released!
Time of Update: 2021-10-21
, the proportion of patients with type 1 diabetes is as high as 52%, with upper middle income Countries (UMICs), low-middle-income countries (LMICs) and low-income countries (LIC) accounted for 19%, 27%, and 2%, respectively <span
-
Express significantly improves the vision of patients with diabetic macular edema, and the Phase 2 clinical results of the innovative bicyclic peptide therapy are positive
Time of Update: 2021-10-21
▎Editor of WuXi AppTec's content team recently, Oxurion announced that THR-149, an investigational therapy jointly developed with Bicycle Therapeutics, has obtained positive results in a phase 2 clinical trial for the treatment of patients with diabetic macular edema (DME) .
-
LANCET sub-news: "Thyroid Eye Disease" treatment, statins may offer "wonderful work"
Time of Update: 2021-10-21
This study shows that the addition of oral atorvastatin to the ivGC regimen can improve the outcome of Graves ophthalmopathy in patients with moderate to severe active eye disease with hypercholesterolemia .
-
2 cases, 4 questions, let you sort out how to manage patients with diabetes and CKD (drug management)
Time of Update: 2021-10-21
Analysis For diabetic patients, the commonly used injection drugs include insulin and glucagon-like peptide-1 (GLP-1) receptor agonists .
-
Chongyang Special Edition Reveals the "Love, Hate and Enmity" between Thyroid Hormone and Health and Longevity (Part 1)
Time of Update: 2021-10-21
➤70-80-year-old elderly patients with subclinical hypothyroidism: ①TSH≥10mU/L: If there are symptoms of hypothyroidism and cardiovascular disease risk factors, consider LT4 treatment; ②TSH<10mU/L: It is recommended to follow-up observation and monitor every 6 months 1 Secondary thyroid function .
-
On the Double Ninth Festival, Caring for the Elderly——An Expert's Message from China's First Guide to Diabetes for the Elderly
Time of Update: 2021-10-21
Professor Guo pointed out that elderly patients with diabetes have their particularities, including relatively poor cognitive function, more complications and/or concomitant diseases, and the presence of multiple medications, Features such as decreased liver and kidney function .
-
Cell Reports Jianyuan Zhao's team reveals a new pathological mechanism of homocysteine modification in the development of diabetes
Time of Update: 2021-10-21
Sciences of Fudan University published an article Homocysteine inhibits pro-insulin receptor cleavage and causes insulin resistance via protein cysteine-homocysteinylation in Cell Reports, explaining the secrets <span
-
Results of Phase II Study of New Drug for Osteoporosis Treatment-Oral PTH Announced!
Time of Update: 2021-10-21
Introduction: Oral parathyroid hormone (PTH 1-34, tablet) EB 613 achieved the main efficacy results in a phase 2 dose study involving low bone mineral density (BMD) postmenopausal women .
-
Wonderful review of Food Frontiers: Research progress and opportunities of dietary polyphenols as hypoglycemic drugs
Time of Update: 2021-10-21
regulating sugar metabolism and the latest progress in clinical trials, providing new insights for nutritional intervention in the changes and regulation of sugar metabolism and innovative dietary polyphenol nutrition and health foods <br
-
JAMA Netw Open: Outcome Characteristics of Surgical Treatment of Pulmonary Neuroendocrine Tumors Related to Cushing Syndrome
Time of Update: 2021-10-20
that cause Cushing’s syndrome is associated with a high incidence . Because the knowledge is based on rare reports of very few patients, the best management</span
-
Is supplementing with probiotics an IQ tax?
Time of Update: 2021-10-20
Immunization preventionThis study aims to synthesize more high-quality randomized controlled trials (RCTs) to provide evidence of the effects of probiotic supplements on blood sugar control, insulin resistance/sensitivity and GDM prevention in pregnant women .
-
Diabetes Obes Metab: The effect of SGLT-2 inhibitors on serum uric acid levels in patients with T2DM
Time of Update: 2021-10-20
Original Source: Effects of SGLT-2 inhibitors ON URIC acid serum in patients with T2DM: A Systematic Review and Meta-Network the Analysis in this message
-
Br J Pharmacol: Butyrate improves skeletal muscle atrophy in diabetic nephropathy by enhancing intestinal barrier function and FFA2-mediated PI3K/AKT/mTOR signaling pathway
Time of Update: 2021-10-20
Butyrate enhances the intestinal barrier function and activates the PI3K/AKT/mTOR pathway mediated by FFA2, which has a protective effect on DN-induced muscle atrophy .
-
NEJM: Treatment effect of Enpagliflozin in patients with heart failure with normal ejection fraction
Time of Update: 2021-10-20
Enpagliflozin reduces the combined risk of cardiovascular death or hospitalization for heart failure in patients with heart failure with a normal ejection fraction, regardless of whether they are associated with diabetes .
-
JAMA: The latest evidence report on screening for gestational diabetes.
Time of Update: 2021-10-20
At or after 24 weeks of gestation, treatment of gestational diabetes is significantly associated with improved health outcomes .
-
Clin Chem: The relationship between the plasma phospholipid fatty acid profile during pregnancy and the diagnosis and treatment of gestational diabetes
Time of Update: 2021-10-20
Background: Plasma phospholipid fatty acids (FAs) in the first and second trimester of pregnancy have a prospective relationship with the risk of gestational diabetes (GDM) .
